Cart summary

You have no items in your shopping cart.

A 839977

SKU: orb2901640

Description

A 839977 is a P2X7 selective antagonist; it blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20 nM, 42 nM and 150 nM respectively) and reduces inflammatory and neuropathic pain in animal models; the antihyperalgesic effects of P2X7 receptor blockadeare mediated by blocking the release of IL-1beta.

Images & Validation

Key Properties

CAS Number870061-27-1
MW413.26
Purity>98% (HPLC)
FormulaC19H14Cl2N6O
SMILESClc1cccc(c1Cl)-n1nnnc1NCc1ccccc1Oc1ccccn1
TargetCalcium Channel
SolubilityIn Vitro: DMSO : 100 mg/mL (241.98 mM; Ultrasonic )

Bioactivity

In Vivo
A 839977 (30 μmol/kg, 100 μmol/kg, 300 μmol/kg; pre-injected 30mins) dose-dependently reduces thermal hyperalgesia produced by intraplantar administration of complete Freund's adjuvant (CFA) in rats. A 839977 (10 μmol/kg, 30 μmol/kg, 100 μmol/kg; pre-injected 30mins) produces robust antihyperalgesia in the CFA model of inflammatory pain in wild-type mice, but it has no effect on IL-1alphabeta knockout mice. A 839977 attenuates dorsal horn neuronal responses in cancer bearing animals. Animal model: Male Sprague-Dawley, BALB/c mice and IL-1 (/) mice for CFA-induced chronic inflammatory. Dosage: 30 μmol/kg, 100 μmol/kg, 300 μmol/kg (rat); 10 μmol/kg, 30 μmol/kg, 100 μmol/kg (mice). Administration: Injection; pre-injected 30mins. Result: Attenuated CFA-induced thermal hyperalgesia in a dose-related manner in rat and mice, but has no effect on IL-1 (/) mice.
In Vitro
A 839977 selectively blocks BzATP-evoked calcium influx at mammalian P2X7 receptors, (IC50 = 20-150 nM), which blocks agonist-evoked YO-PRO uptake and IL-1beta release from differentiated human THP-1 cells, it has been shown to reduce inflammatory and neuropathic pain in animal models. A 839977 (50 nM, pre-treatment 1 hour) significantly prevents pressure-induced rise of IL-1β priming in optic nerve astrocytes. RT-PCR Cell line: Optic nerve astrocyte cells. Concentration: 50 nM. Incubation time: 1 hour(pre-treatment). Result: Prevented the IL-1β priming in astrocyte cells

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • A 839977 [orb1707735]

    98.01%

    870061-27-1

    413.26

    C19H14Cl2N6O

    5 mg, 1 mg, 2 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

A 839977 (orb2901640)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

100 mg
500 mg
2 mg
$ 100.00
5 mg
$ 130.00